share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director BROWN C DAVID II

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director BROWN C DAVID II

西維斯健康 | 4:持股變動聲明-董事 BROWN C DAVID II
美股SEC公告 ·  05/17 23:39

Moomoo AI 已提取核心訊息

On May 16, 2024, BROWN C DAVID II, reported a completed transaction of purchasing 2,314 shares of CVS Health Corp (CVS) common stock at a price of $57.52 per share. Following this transaction, BROWN C DAVID II directly holds a total of 121,434 shares in the company. The transaction, which involved direct ownership, was classified as a grant, award, or other acquisition, according to the transaction code description.
On May 16, 2024, BROWN C DAVID II, reported a completed transaction of purchasing 2,314 shares of CVS Health Corp (CVS) common stock at a price of $57.52 per share. Following this transaction, BROWN C DAVID II directly holds a total of 121,434 shares in the company. The transaction, which involved direct ownership, was classified as a grant, award, or other acquisition, according to the transaction code description.
2024年5月16日,BROWN C DAVID II報告完成了以每股57.52美元的價格購買2314股CVS Health Corp(CVS)普通股的交易。在這筆交易之後,BROWN C DAVID II直接持有該公司共計121,434股股份。根據交易代碼的描述,該交易涉及直接所有權,被歸類爲贈款、獎勵或其他收購。
2024年5月16日,BROWN C DAVID II報告完成了以每股57.52美元的價格購買2314股CVS Health Corp(CVS)普通股的交易。在這筆交易之後,BROWN C DAVID II直接持有該公司共計121,434股股份。根據交易代碼的描述,該交易涉及直接所有權,被歸類爲贈款、獎勵或其他收購。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息